共 50 条
- [1] Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation LEUKEMIA RESEARCH REPORTS, 2022, 17
- [7] Successful treatment of refractory pure red cell aplasia in major ABO-mismatched allogeneic hematopoietic stem cell transplant with single agent Ibrutinib Bone Marrow Transplantation, 2022, 57 : 830 - 833